Cognitive Disorders in Patients with Chronic Kidney Disease
DOI:
https://doi.org/10.51985/Abstract
Objective: To asses and identify prevalence and severity of cognitive disorders through cognitive screening test in patients with Chronic Kidney Disease (CKD).
Study Design and Setting: This observational cross-sectional study was conducted in Nephrology Department at PNS Shifa hospital Karachi from February 01, 2025 to July 31, 2025.
Methodology: Total of 201 patients who either visited OPD or came in dialysis center were included in study. All adult patients with CKD, aged above 18 years, either gender, with or without comorbids were enrolled after informed consent both verbal and written. A set questionnaire was used for data collection, subsequently was analyzed by using SPSS version 25.
Results: Cognitive impairment (CI) has been found in 122 (60.69%) patients suffering from CKD while 79 (30.3%) were devoid of such presentation. Significant point of note among cognitively impaired persons was that greater proportion had mild form of disease, i-e: 79 (64.75%) otherwise 28 (22.9%) patients had revealed moderate form and 8 (6.5%) patients had severe form of cognitive disorder. It was also evident that moderate and severe form of CI were more pronounced in patients who were on maintenance hemodialysis.
Conclusion: CKD patients particularly those who are on maintenance hemodialysis are prone to suffer from cognitive disorders, an overlooked complication. It is necessary to make physicians/ Nephrologists aware of this complication so that all patients with CKD maybe screened for CI and early application of required therapy be initiated to curb further deterioration.
Key Words: Chronic Kidney Disease: Cognitive disorders: Cognitive Screening Test
References
1. Levey AS, Coresh J. CKD. Lancet. 2012 Jan 14: 379(9811):
165-80. DOI: https://doi.org/10.1016/S0140-6736(11)60178-
5.
2. Quinn MP, Cardwell CR, Kee F, Maxwell AP, Savage G,
McCarron P et al. The finding of reduced estimated glomerular
filtration rate is associated with increased mortality in a large
UK population. Nephrol Dial Transplant. 2011 Mar: 26(3):875-
80. DOI: https://doi.org/10.1093/ndt/gfq505.
3. Golenia A, Malyszko JS, Malyszko J. CI and Kidney Transplantation: Underestimated, Underrecognized but Clinically
Relevant Problem. Kidney Blood Press Res. 2022: 47(7):459-
466. DOI: https://doi.org/10.1159/000521907.
4. Murray AM. CI in the aging dialysis and CKD populations:
an occult burden. Adv Chronic Kidney Dis. 2008 Apr:
15(2):123-32. DOI: https://doi.org/10.1053/j.ackd.2008.01.010.5. Liabeuf S, Pepin M, Franssen CFM, Viggiano D, Carriazo S,
Gansevoort RT et al. CKD and neurological disorders: are
uraemic toxins the missing piece of the puzzle? Nephrol Dial
Transplant. 2022 Jul 26: 37(8):1589. DOI: https://doi.org
/10.1093/ndt/gfac015.
6. Drew DA, Weiner DE, Sarnak MJ. CI in CKD: Pathophysiology, Management, and Prevention. Am J Kidney Dis. 2019
Dec: 74(6):782-790. DOI: https://doi.org/10.1053/j.ajkd
.2019.05.017.
7. Sachdev PS, Mohan A, Taylor L, Jeste DV. DSM-5 and Mental
Disorders in Older Individuals: An Overview. Harv Rev
Psychiatry. 2015 Sep-Oct: 23(5):320-8. DOI: https://doi.org
/10.1097/HRP.0000000000000090.
8. Hugo J, Ganguli M. Dementia and CI: epidemiology, diagnosis,
and treatment. Clin Geriatr Med. 2014 Aug: 30(3):421-42.
DOI: https://doi.org/10.1016/j.cger.2014.04.001.
9. Nikitina AA, Khrulev AE, Kuznetsov AN. Cognitive disorders
in patients with CKD in pre-dialysis period. Saratov Medical
Journal 2021: 2 (4): e0403. DOI: https://doi.org/10.15275/
sarmj.2021.0403.
10. Kelly DM and Rothwell PM. Disentangling the Relationship
Between CKD and Cognitive Disorders. Front. Neurol. 2022,
13:830064. DOI: https://doi.org/10.3389/fneur.2022.830064.
11. Drew DA, Tighiouart H, Rollins J, Duncan S, Babroudi S,
Scott T, Weiner DE, Sarnak MJ. Evaluation of Screening
Tests for CI in Patients Receiving Maintenance Hemodialysis.
J Am Soc Nephrol. 2020 Apr: 31(4):855-864. DOI: https://doi.org/10.1681/ASN.2019100988.
12. Sudrajat A, Priyono D, Harun H, Kurniati R, Mulyana R.
CKD Related to Cognitive Disorders in the Elderly: A Narrative
Literature Review. Bioscientia Medicina: Journal of Biomedicine & Translational Research. Vol. 6 No. 14 (2022): 2651-
2658. DOI: https://doi.org/10.37275/bsm.v6i14.663.
13. Pepin M, Boucquemont J, Turinici M, Levassort H, Cheddani
L, Frimat L et al. MO503: Cognitive Performance in Patients
With CKD: Results From the CKD-Rein Cohort Study. Nephrology Dialysis Transplantation, Volume 37, Issue Supplement
3, 2022, gfac071.034. DOI: https://doi.org/10.1093/ndt
/gfac071.034.
14. Lan DTN. Prevalence of depression, cognition impairment,
nutrition and related factors in patients with CKD stage 3 -
5. Journal of Medicine and Pharmacy, 2022, 55-61. DOI:
https://doi.org/10.34071/jmp.2022.6.755-61.
15. Pépin M, Klimkowicz-Mrowiec A, Godefroy O, Delgado P,
Carriazo S, Ferreira AC et al. Cognitive disorders in patients
with CKD: Approaches to prevention and treatment. Eur J
Neurol. 2023 Sep: 30(9):2899-2911. DOI: https://doi.org/
10.1111/ ene.15928.
16. Khudayarova S,·Rakhmatullaevna G. Cognitive disorders in
patients with CKD (CKD) and its relationship with the concentration in the blood of the biomarker of kidney damage
cystatin C. Journal of the Neurological Sciences 455 (2023)
121173. DOI: https://doi.org/10.1016/j.jns.2023.121692.
17. Hobson P, Kumwenda M, Shrikanth S, Nair H, Wong S. Risk
and incidence of CI in patients with CKD and diabetes: the
results from a longitudinal study in a community cohort of
patients and an age and gender-matched control cohort in
North Wales, UK. BMJ Open. 2022 Mar 11: 12(3):e053008.
DOI: https://doi.org/10.1136/bmjopen-2021-053008.
18. Huang Z, Yaffe K, Pan Y, Li C, Unruh M, Weir M et al. CKD
Severity and Incident CI in Patients with CKD: Findings from
the Chronic Renal Insufficiency Cohort. Circulation, 2025.
DOI: http://doi.org/10.1161/cir.151.suppl_1.p2093.
19. Alexander Z, Seth F, Allison S, Petter B, Zhiying Y, Kalie T
et al. Assessing Cognition in CKD Using the National Institutes
of Health Toolbox. Kidney360 5(6):p 834-840, June 2024.
DOI: https://doi.org/10.34067/KID.0000000000000440.
20. Zhang J, Wu L, Wang P, Pan Y, Dong X, Jia L et al. Prevalence
of CI and its predictors among CKD patients: A systematic
review and meta-analysis. 2024, PLoS ONE 19(6): e0304762.
DOI: https://doi.org/10.1371/journal.pone.0304762.
21. Berger I, Wu S, Masson P, Kelly PJ, Duthie FA, Whiteley W
et al. Cognition in CKD: a systematic review and metaanalysis. BMC Medicine 2016, 14:206. DOI: https://doi.org/10.1186/s12916-016-0745-9.
22. Pépin M, Levassort H, Massy ZA. The impact of CKD on
cognitive function. Current Opinion in Nephrology and
Hypertension 33(6):p 566-572, November 2024. | DOI:
https://doi.org/10.1097/MNH.0000000000001017.
23. El Belbessi AS, El Gohary IE, Sheshtawi HA, Abdulmoneim
Mohamed MMM. Cognitive disorders in chronic kidney
disease and hemodialysis patients. J Egypt Soc Nephrol
Transplant. 2018 Oct-Dec: 18(4):130-6. DOI: https://doi.org/10.4103/jesnt.jesnt_21_18.
24. Mitterhofer AP, Testorio M, Frassetti N, Aceto P, Galani A,
Lai C. Neurological, psychological, and cognitive disorders
in patients with chronic kidney disease on conservative and
replacement therapy. Medicine (Baltimore). 2016 Nov:
95(48):e5191. DOI: https://doi.org/10.1097/MD.
0000000000005191.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0
